Searched for
EUROPEAN DRUGMAKERS
Europe's STOXX 600 on track for biggest quarterly gain in over five years on AI boostEuropean markets are soaring, marking their best quarterly performance in over five years. Optimism surrounding artificial intelligence and...- School assembly news headlines for June 16: Top national, international, business, sports update and thought of the dayIndia and Slovakia elevate ties to a comprehensive partnership. A rival tutor accuses Khan Sir of murder. Delhi census Phase 1 records over...
- European shares rally as Middle East peace hopes drag oil prices lowerEuropean shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...
- Global Market | European stocks rally as oil falls on hopes for US-Iran dealThe benchmark snapped a four-day losing streak on Thursday, as investors digested the European Central Bank's rate hike and largely looked...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- Global Markets: European shares edge higher with banks in the lead; the Middle East in focusEuropean markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after ...
- Novo Holdings commits 500 million euros in new European tech growth fundNovo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...
- Global Markets: European stocks rise as STMicroelectronics' forecasts lift tech stocksEuropean shares climbed Tuesday, led by technology stocks boosted by strong forecasts from STMicroelectronics amid AI demand. Investors awa...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Global Markets | European shares subdued as US-Iran talks stall; corporate earnings on tapEuropean shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Soleno withdraws EU rare disease drug application ahead of Neurocrine takeoverSoleno Therapeutics has withdrawn its European drug application. This decision stems from its acquirer, Neurocrine Biosciences, prioritizin...
- Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...
- European shares flat as tech losses counter healthcare boostEuropean shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's strong earnings...
- EU plans to boost reach of Pfizer COVID-19 shotThe European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It ...
- Aurobindo Pharma looks to push deeper into EU, US over next 3-4 years"Lower generic penetration in Italy, Spain, Portugal and France offers future growth potential as share of generics improves," the company ...
- Pfizer has not discussed AstraZeneca bid with regulators: European Union's AlmuniaPfizer is seeking to acquire Britain's second-biggest drugmaker and may have to sweeten its offer after AstraZeneca rejected the bid.
- Lupin Q2 net profit up 24% at Rs 266.9 crNet sales grew by 23.57% to Rs 1,741.7 crore during the second quarter from Rs 1,409.4 cr in the same period last fiscal.
- Glaxo, Sanofi-Aventis eye Shantha BiotechIndia’s Shantha Biotech is on the block, with European drugmakers GlaxoSmithKline and Sanofi-Aventis in separate talks to buy out its Franc...
- Global pharma MNCs find China toughColleen Cheng and Angel Chen, Chinese marketing executives in their 30s, should be the ideal customers for US and European drugmakers.
Load More
